Treating cerebrovascular diseases with erythropoietin and granulocyte-colony stimulating factor jointly
US7618938B2 · kind B2 · utility
3Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2007 |
| Grant date | Nov 17, 2009 |
| Priority date | — |
| Expiry date | Feb 7, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating a cerebrovascular disease with erythropoietin (EPO) and granulocyte-colony stimulating factor (G-CSF) jointly by first identifying a subject in need of the treatment and then administering to the subject an effective combined amount of EPO and G-CSF. Also disclosed is a method for increasing in a subject expression of EPO with G-CSF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.